Caxton Associates (UK)’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,629
Closed -$307K 697
2025
Q1
$307K Buy
+2,629
New +$307K 0.01% 623